...
首页> 外文期刊>Human Molecular Genetics >Fibroblast phenotype in male carriers of FMR1 premutation alleles
【24h】

Fibroblast phenotype in male carriers of FMR1 premutation alleles

机译:FMR1突变前等位基因男性携带者的成纤维细胞表型

获取原文

摘要

Fragile X-associated tremor/ataxia syndrome (FXTAS) is an adult-onset neurodegenerative disorder among carriers of premutation expansions (55–200 CGG repeats) of the fragile X mental retardation 1 (FMR1) gene. The clinical features of FXTAS, as well as various forms of clinical involvement in carriers without FXTAS, are thought to arise through a direct toxic gain of function of high levels of FMR1 mRNA containing the expanded CGG repeat. Here we report a cellular endophenotype involving increased stress response (HSP27, HSP70 and CRYAB) and altered lamin A/C expression/organization in cultured skin fibroblasts from 11 male carriers of premutation alleles of the FMR1 gene, including six patients with FXTAS and five premutation carriers with no clinical evidence of FXTAS, compared with six controls. A similar abnormal cellular phenotype was found in CNS tissue from 10 patients with FXTAS. Finally, there is an analogous abnormal cellular distribution of lamin A/C isoforms in knock-in mice bearing the expanded CGG repeat in the murine Fmr1 gene. These alterations are evident even in mouse embryonic fibroblasts, raising the possibility that, in humans, the expanded-repeat mRNA triggers pathogenic mechanisms early in development, thus providing a molecular basis for the neurodevelopmental abnormalities observed in some children and clinical symptoms in some adults who are carriers of premutation FMR1 alleles. Cellular dysregulation in fibroblasts represents a novel and highly advantageous model for investigating disease pathogenesis in premutation carriers and for quantifying and monitoring disease progression. Fibroblast studies may also prove useful in screening and testing the efficacy of therapeutic interventions.
机译:脆性X相关震颤/共济失调综合征(FXTAS)是脆性X智力低下1(FMR1)基因的预突变扩展(55-200个CGG重复)携带者中的成年性神经退行性疾病。 FXTAS的临床特征以及无FXTAS的携带者的各种形式的临床参与被认为是由含有扩展CGG重复序列的高水平FMR1 mRNA功能的直接毒性获得的。在这里,我们报告了一种细胞内表型,涉及应激反应(HSP27,HSP70和CRYAB)增加和培养的皮肤成纤维细胞中层粘蛋白A / C表达/组织的改变,该皮肤成纤维细胞来自FMR1基因预突变等位基因的11位男性携带者,包括6名FXTAS和5名预突变没有FXTAS临床证据的携带者,与六个对照组相比。在10名FXTAS患者的CNS组织中发现了类似的异常细胞表型。最后,在鼠Fmr1基因中带有扩展的CGG重复序列的敲入小鼠中,lamin A / C亚型具有类似的异常细胞分布。这些改变甚至在小鼠胚胎成纤维细胞中也很明显,增加了人类重复扩增的mRNA触发发育早期的致病机制的可能性,从而为某些儿童中观察到的神经发育异常和某些成年人的临床症状提供了分子基础。是突变前FMR1等位基因的载体。成纤维细胞中的细胞失调代表了一种新颖且高度有利的模型,用于研究突变前携带者中的疾病发病机理以及定量和监测疾病进展。成纤维细胞研究也可能被证明可用于筛选和测试治疗性干预措施的功效。

著录项

  • 来源
    《Human Molecular Genetics 》 |2010年第2期| p.299-312| 共14页
  • 作者单位

    Department of Biochemistry and Molecular Medicine and;

    Department of Biochemistry and Molecular Medicine and;

    CBG-Department of Clinical Genetics, Erasmus MC, Rotterdam, The Netherlands,;

    Department of Biochemistry and Molecular Medicine and|M.I.N.D. Institute,;

    Department of Biochemistry and Molecular Medicine and;

    Departments of Pediatrics, Neurological Sciences, and Biochemistry,;

    Departments of Neurological Sciences and Pharmacology and;

    Department of Pediatrics, Rush University Medical Center, Chicago, IL, USA;

    Department of Pediatrics, Rush University Medical Center, Chicago, IL, USA;

    Division of Biostatistics, Department of Public Health Sciences, School of Medicine, University of California, Davis, CA, USA,;

    Division of Biostatistics, Department of Public Health Sciences, School of Medicine, University of California, Davis, CA, USA,;

    Department of Biochemistry and Molecular Medicine and;

    Department of Biochemistry and Molecular Medicine and;

    Department of Pathology and;

    CBG-Department of Clinical Genetics, Erasmus MC, Rotterdam, The Netherlands,;

    M.I.N.D. Institute,|Department of Pediatrics, University of California, Davis, Health System, Sacramento, CA, USA,;

  • 收录信息
  • 原文格式 PDF
  • 正文语种
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号